Table 7 Sub-gender analysis for cumulative dose and frequency of diuretics administered to patients during hospitalization
From: Could admission level of uric acid predict total diuretic dose in acute heart failure?
|  | Variables | Route | hyperuricemia Group (Mean ± SD) (Frequency/Percentage) | Natural uric acid Group (Mean ± SD) (Frequency/Percentage) | Total (Mean ± SD) (Frequency/Percentage) | P-value |
|---|---|---|---|---|---|---|
Male | Furosemide | Oral | 132.07 ± 180.30 | 129.09 ± 230.36 | 131.56 ± 187.77 | 0.685 |
IV | 570.83 ± 376.48 | 349.09 ± 226.86 | 532.71 ± 363.69 | 0.73 | ||
Thiazides acetazolamide | Oral | 570.83 ± 36.40 | 349.10 ± 226.87 | 5.38 ± 33.21 | 0.233 | |
Oral | 36.363 ± 212.01 | 0.0 ± 0.0 | 30.30 ± 193.72 | 0.252 | ||
Female | Furosemide | Oral | 139.09 ± 184.18 | 266.66 ± 146.78 | 166.42 ± 182.25 | 0.562 |
IV | 601.86 ± 492.99 | 373.33 ± 510.56 | 552.89 ± 496.41 | 0.881 | ||
Thiazides acetazolamide | Oral | 25.0 ± 85.97 | 0 | 19.35 ± 76.02 | 0.107 | |
Oral | 0 | 0 | 0 | - |